SAITTA, Carlo
 Distribuzione geografica
Continente #
EU - Europa 6.369
NA - Nord America 4.888
AS - Asia 2.812
SA - Sud America 840
AF - Africa 117
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.039
Nazione #
US - Stati Uniti d'America 4.798
RU - Federazione Russa 3.373
SG - Singapore 1.135
CN - Cina 840
BR - Brasile 722
IE - Irlanda 691
SE - Svezia 555
IT - Italia 524
HK - Hong Kong 288
DE - Germania 271
PL - Polonia 237
VN - Vietnam 175
FR - Francia 163
FI - Finlandia 146
GB - Regno Unito 127
IN - India 105
UA - Ucraina 100
AR - Argentina 44
BD - Bangladesh 38
MX - Messico 38
BE - Belgio 37
CA - Canada 36
NL - Olanda 35
ZA - Sudafrica 31
AT - Austria 28
TR - Turchia 28
ID - Indonesia 27
PK - Pakistan 23
CI - Costa d'Avorio 22
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
IQ - Iraq 19
JP - Giappone 19
MA - Marocco 18
EC - Ecuador 16
ES - Italia 16
CO - Colombia 14
AE - Emirati Arabi Uniti 12
PH - Filippine 11
VE - Venezuela 11
PY - Paraguay 10
SA - Arabia Saudita 10
JO - Giordania 9
KE - Kenya 9
EG - Egitto 8
DZ - Algeria 7
EE - Estonia 7
IL - Israele 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
BO - Bolivia 6
CH - Svizzera 6
CL - Cile 6
MY - Malesia 6
UY - Uruguay 6
KG - Kirghizistan 5
NP - Nepal 5
OM - Oman 5
AL - Albania 4
AU - Australia 4
BY - Bielorussia 4
GH - Ghana 4
JM - Giamaica 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
AZ - Azerbaigian 3
GE - Georgia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
GD - Grenada 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
NO - Norvegia 2
SN - Senegal 2
SV - El Salvador 2
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 15.028
Città #
Moscow 973
Ashburn 953
Dallas 712
Dublin 691
Singapore 683
Chandler 502
Nyköping 329
Hong Kong 288
Beijing 257
Messina 255
Jacksonville 229
Warsaw 229
San Jose 202
The Dalles 158
Los Angeles 121
Ann Arbor 120
Dearborn 107
Lauterbourg 89
Munich 87
Princeton 83
Medford 78
São Paulo 70
New York 67
Cambridge 62
Des Moines 58
Boardman 56
Ho Chi Minh City 53
Houston 52
Helsinki 43
Tianjin 43
Buffalo 41
Turku 41
Bremen 38
Orem 38
Brussels 37
Frankfurt am Main 35
Jinan 34
Guangzhou 32
Council Bluffs 30
Hanoi 30
Redondo Beach 30
Shenyang 27
Brasília 26
Hyderabad 25
Pune 25
Brooklyn 24
Santa Clara 24
Chennai 23
Abidjan 22
Nuremberg 22
Rio de Janeiro 22
Wilmington 22
Belo Horizonte 21
Nanjing 21
Catania 20
Rome 19
Tokyo 19
Boston 18
Dong Ket 18
San Mateo 18
Shenzhen 18
Woodbridge 18
Amsterdam 17
Lancaster 17
Jakarta 16
London 16
Shanghai 16
Haikou 15
Johannesburg 15
Vienna 15
Denver 14
Tashkent 14
Avola 13
Montreal 13
Zhengzhou 13
Atlanta 12
Curitiba 12
Düsseldorf 12
Haiphong 12
Hebei 12
Phoenix 12
Seattle 12
Hangzhou 11
Lahore 11
Mexico City 11
Porto Alegre 11
Stockholm 11
Chicago 10
Manchester 10
Ningbo 10
Poplar 10
Taizhou 10
Ankara 9
Baghdad 9
Brno 9
Campinas 9
Falls Church 9
Lappeenranta 9
New Delhi 9
Palermo 9
Totale 8.943
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 266
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 264
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 260
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 248
Atrial fibrillation in patients with cirrhosis 244
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 239
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 220
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 217
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 214
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 213
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 209
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 208
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 207
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 206
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 205
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 202
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 202
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 200
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 197
Erectile dysfunction in compensated liver cirrhosis 197
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 195
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 192
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 190
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 189
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 188
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 187
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 182
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 179
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 178
Mitochondrial DNA is a target of HBV integration 178
Circulating progenitor cells and the elderly: a seven-year observational study. 177
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 173
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 172
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 171
Anatomic variations: a rare variant of formation of the portal vein 171
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 166
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 164
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 161
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 160
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 159
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 158
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 157
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 155
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 155
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 153
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 150
Potenziali indicatori di longevità in una popolazione di anziani siciliani 147
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 147
Circulating progenitor cells and high density lipoprotein levels in elderly 145
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 145
Obesity and liver cancer 144
Pattern of macrovascular invasion in hepatocellular carcinoma 141
The changing scenario of hepatocellular carcinoma in Italy: an update 141
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 139
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 138
Fever and rhomboid target lesion in decompensated cirrhosis 137
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 134
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 133
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 130
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 130
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 130
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 129
Monofocal hepatocellular carcinoma: How much does size matter? 126
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 125
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 124
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 119
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 116
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 114
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 111
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 111
Arterial hypertension as a comorbidity of cirrhosis 110
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 110
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 110
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 109
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 109
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 107
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 105
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 101
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 100
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 98
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 92
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 92
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 91
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 89
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 89
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 87
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 86
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 86
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 86
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 85
Occult hepatitis B virus and hepatocellular carcinoma. 84
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 83
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 82
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 82
Occult hepatitis B virus infection: an update 79
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 78
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 71
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 70
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 67
null 66
Totale 14.738
Categoria #
all - tutte 45.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 95 30 36
2021/2022616 11 55 19 25 27 15 37 23 9 127 87 181
2022/20231.924 140 206 76 154 162 174 24 126 803 10 36 13
2023/2024484 37 79 27 40 32 109 3 22 2 49 21 63
2024/20252.519 30 70 75 154 162 128 95 452 584 159 245 365
2025/20267.904 423 623 619 493 643 1.658 947 1.066 1.091 341 0 0
Totale 15.301